22/09/2025
A critical and often-misunderstood hematologic disorder: aplastic anemia. The term itself reveals the core problem: "aplastic" refers to the bone marrow's inability to form new cells, while "anemia" points to a shortage of red blood cells.
The condition is characterized by pancytopenia, a failure to produce all three major blood components: red blood cells, white blood cells, and platelets. This leaves patients profoundly vulnerable, and the symptoms tell a clear story of what's missing:
While rare, with an incidence of about 1 to 4 cases per million people, aplastic anemia can be both acquired and inherited. The most common cause is an acquired autoimmune response, where the body's immune system attacks its own stem cells in the bone marrow. Triggers for this autoimmune reaction can be varied and include viral infections like hepatitis, certain medications, or exposure to toxic chemicals like benzene. In many cases, the cause remains unknown, a condition known as "idiopathic" aplastic anemia.
Accurate diagnosis is crucial to distinguish aplastic anemia from other bone marrow disorders, and it requires a bone marrow biopsy, which reveals a hypocellular marrow—meaning it's mostly fat rather than blood-forming cells.
